STD Pharmaceutical Products Ltd. · 66-41 · UNITED KINGDOM
For STD Pharmaceutical Products Ltd. · 66-41 · UNITED KINGDOM, import alert is 66-41; import alert name is Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S; country is UNITED KINGDOM; product code is 55 - - - -- Pharm Necess & Ctnr For Drug/Bio | 58 - - - -- Human and Animal Therapeutic Biologic and Biosimilar Drugs | 60 - - - -- Human and Animal Drugs | 61 - - - -- Human and Animal Drugs | 62 - - - -- Human and Animal Drugs | 63 - - - -- Human and Animal Drugs | 64 - - - -- Human and Animal Drugs | 65 - - - -- Human and Animal Drugs | 66 - - - -- Human and Animal Drugs; date published is 11/06/2018; address is Plough Lane , Hereford, UNITED KINGDOM, verified against its source on 2026-09-16.
- Firm
- STD Pharmaceutical Products Ltd. verified
- Import alert
- 66-41
- Import alert name
- Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S.
- Country
- UNITED KINGDOM verified
- Address
- Plough Lane , Hereford, UNITED KINGDOM verified
- Date published
- 11/06/2018 verified
- Product code
- 55 - - - -- Pharm Necess & Ctnr For Drug/Bio | 58 - - - -- Human and Animal Therapeutic Biologic and Biosimilar Drugs | 60 - - - -- Human and Animal Drugs | 61 - - - -- Human and Animal Drugs | 62 - - - -- Human and Animal Drugs | 63 - - - -- Human and Animal Drugs | 64 - - - -- Human and Animal Drugs | 65 - - - -- Human and Animal Drugs | 66 - - - -- Human and Animal Drugs each item verified
- FDA notes
- Sodium Tetradecyl Sulfate Injection; The product is shipped under various brand names to include: STD Injection, Thromboject 1% and 3%, and Fibro-Vein. Sodium Tetradecyl Sulfate products intended for use as a human drug product that either are the subject of an approved new drug application or exempt from such application (i.e. active IND) are not subject to DWPE under this listing. | Sodium Tetradecyl Sulfate Injection; The product is shipped under various brand names to include: STD Injection, Thromboject 1% and 3%, and Fibro-Vein. Sodium Tetradecyl Sulfate products intended for use as a human drug product that either are the subject of an approved new drug application or exempt from such application (i.e. active IND) are not subject to DWPE under this listing. | Sodium Tetradecyl Sulfate Injection; The product is shipped under various brand names to include: STD Injection, Thromboject 1% and 3%, and Fibro-Vein. Sodium Tetradecyl Sulfate products intended for use as a human drug product that either are the subject of an approved new drug application or exempt from such application (i.e. active IND) are not subject to DWPE under this listing. | Sodium Tetradecyl Sulfate Injection; The product is shipped under various brand names to include: STD Injection, Thromboject 1% and 3%, and Fibro-Vein. Sodium Tetradecyl Sulfate products intended for use as a human drug product that either are the subject of an approved new drug application or exempt from such application (i.e. active IND) are not subject to DWPE under this listing. | Sodium Tetradecyl Sulfate Injection; The product is shipped under various brand names to include: STD Injection, Thromboject 1% and 3%, and Fibro-Vein. Sodium Tetradecyl Sulfate products intended for use as a human drug product that either are the subject of an approved new drug application or exempt from such application (i.e. active IND) are not subject to DWPE under this listing. | Sodium Tetradecyl Sulfate Injection; The product is shipped under various brand names to include: STD Injection, Thromboject 1% and 3%, and Fibro-Vein. Sodium Tetradecyl Sulfate products intended for use as a human drug product that either are the subject of an approved new drug application or exempt from such application (i.e. active IND) are not subject to DWPE under this listing. | Sodium Tetradecyl Sulfate Injection; The product is shipped under various brand names to include: STD Injection, Thromboject 1% and 3%, and Fibro-Vein. Sodium Tetradecyl Sulfate products intended for use as a human drug product that either are the subject of an approved new drug application or exempt from such application (i.e. active IND) are not subject to DWPE under this listing. | Sodium Tetradecyl Sulfate Injection; The product is shipped under various brand names to include: STD Injection, Thromboject 1% and 3%, and Fibro-Vein. Sodium Tetradecyl Sulfate products intended for use as a human drug product that either are the subject of an approved new drug application or exempt from such application (i.e. active IND) are not subject to DWPE under this listing. each item verified
What the source says
STD Pharmaceutical Products Ltd. Date Published : 11/06/2018 Plough Lane , Hereford, UNITED KINGDOM 55 - - - -- Pharm Necess & Ctnr For Drug/Bio Date Published: 11/06/2018 Notes: Sodium Tetradecyl Sulfate Injection; The product is shipped under various brand names to include: STD Injection, Thromboject 1% and 3%, and Fibro-Vein. Sodium Tetradecyl Sulfate products intended for use as a human drug product that either are the subject of an approved new drug application or exempt from such application (i.e. active IND) are not subject to DWPE under this listing. 58 - - - -- Human and Animal Therapeutic Biologic and Biosimilar Drugs Date Published: 05/27/2022 60 - - - -- Human and Animal Drugs Date Published: 11/06/2018 Notes: Sodium Tetradecyl Sulfate Injection; The product is shipped under various brand names to include: STD Injection, Thromboject 1% and 3%, and Fibro-Vein. Sodium Tetradecyl Sulfate products intended for use as a human drug product that either are the subject of an approved new drug application or exempt from such application (i.e. active IND) are not subject to DWPE under this listing. 61 - - - -- Human and Animal Drugs Date Published: 11/06/2018 Notes: Sodium Tetradecyl Sulfate Injection; The product is shipped under various brand names to include: STD Injection, Thromboject 1% and 3%, and Fibro-Vein. Sodium Tetradecyl Sulfate products intended for use as a human drug product that either are the subject of an approved new drug application or exempt from such application (i.e. active IND) are not subject to DWPE under this listing. 62 - - - -- Human and Animal Drugs Date Published: 11/06/2018 Notes: Sodium Tetradecyl Sulfate Injection; The product is shipped under various brand names to include: STD Injection, Thromboject 1% and 3%, and Fibro-Vein. Sodium Tetradecyl Sulfate products intended for use as a human drug product that either are the subject of an approved new drug application or exempt from such application (i.e. active IND) are not subject to DWPE under this listing. 63 - - - -- Human and Animal Drugs Date Published: 11/06/2018 Notes: Sodium Tetradecyl Sulfate Injection; The product is shipped under various brand names to include: STD Injection, Thromboject 1% and 3%, and Fibro-Vein. Sodium Tetradecyl Sulfate products intended for use as a human drug product that either are the subject of an approved new drug application or exempt from such application (i.e. active IND) are not subject to DWPE under this listing. 64 - - - -- Human and Animal Drugs Date Published: 11/06/2018 Notes: Sodium Tetradecyl Sulfate Injection; The product is shipped under various brand names to include: STD Injection, Thromboject 1% and 3%, and Fibro-Vein. Sodium Tetradecyl Sulfate products intended for use as a human drug product that either are the subject of an approved new drug application or exempt from such application (i.e. active IND) are not subject to DWPE under this listing. 65 - - - -- Human and Animal Drugs Date Published: 11/06/2018 Notes: Sodium Tetradecyl Sulfate Injection; The product is shipped under various brand names to include: STD Injection, Thromboject 1% and 3%, and Fibro-Vein. Sodium Tetradecyl Sulfate products intended for use as a human drug product that either are the subject of an approved new drug application or exempt from such application (i.e. active IND) are not subject to DWPE under this listing. 66 - - - -- Human and Animal Drugs Date Published: 11/06/2018 Notes: Sodium Tetradecyl Sulfate Injection; The product is shipped under various brand names to include: STD Injection, Thromboject 1% and 3%, and Fibro-Vein. Sodium Tetradecyl Sulfate products intended for use as a human drug product that either are the subject of an approved new drug application or exempt from such application (i.e. active IND) are not subject to DWPE under this listing.
— accessdata.fda.gov, retrieved 2026-09-15
Source
- accessdata.fda.govhttps://www.accessdata.fda.gov/cms_ia/importalert_190.html
This one changes, and we watch it.FDA import alert red lists: firms subject to detention without physical examination is re-read on a schedule and every change is dated. Subscribe: Atom feed · JSON · what has changed so far.